{"id":"https://openalex.org/W3000707262","doi":"https://doi.org/10.1016/s0923-7534(19)66471-9","title":"O-0006 Dose Escalation to Rash for Erlotinib Plus Gemcitabine in Patients with Metastatic Pancreatic Cancer: The Phase II RACHEL (BO21128) Study","display_name":"O-0006 Dose Escalation to Rash for Erlotinib Plus Gemcitabine in Patients with Metastatic Pancreatic Cancer: The Phase II RACHEL (BO21128) Study","publication_year":2012,"publication_date":"2012-06-01","ids":{"openalex":"https://openalex.org/W3000707262","doi":"https://doi.org/10.1016/s0923-7534(19)66471-9","mag":"3000707262"},"language":"en","primary_location":{"id":"doi:10.1016/s0923-7534(19)66471-9","doi":"https://doi.org/10.1016/s0923-7534(19)66471-9","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s0923-7534(19)66471-9","pdf_url":"https://doi.org/10.1016/s0923-7534(19)66471-9","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1016/s0923-7534(19)66471-9","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090645179","display_name":"Eric Van Cutsem","orcid":"https://orcid.org/0000-0002-6372-1230","observed_orcids":["https://orcid.org/0000-0002-6372-1230"]},"institutions":[{"id":"https://openalex.org/I2800231306","display_name":"Universitair Ziekenhuis Leuven","ror":"https://ror.org/0424bsv16","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2800231306"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Eric Van Cutsem","raw_affiliation_strings":["University Hospital Gasthuisberg, Leuven, Flemish Brabant"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital Gasthuisberg, Leuven, Flemish Brabant","institution_ids":["https://openalex.org/I2800231306"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042864391","display_name":"El\u017cbieta Nowara","orcid":"https://orcid.org/0000-0001-5883-6853","observed_orcids":["https://orcid.org/0000-0001-5883-6853"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elzbieta Nowara","raw_affiliation_strings":["Centrum Onkologii Instytut Gliwicach, Gliwice"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centrum Onkologii Instytut Gliwicach, Gliwice","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001591653","display_name":"Tudor\u2013Eliade Ciuleanu","orcid":"https://orcid.org/0009-0006-5351-4234","observed_orcids":["https://orcid.org/0009-0006-5351-4234","https://orcid.org/0000-0003-0958-5597"]},"institutions":[{"id":"https://openalex.org/I4210100616","display_name":"Institute of Oncology Prof. Dr. Ion Chiricuta","ror":"https://ror.org/00nrbsf87","country_code":"RO","type":"facility","lineage":["https://openalex.org/I4210100616"]}],"countries":["RO"],"is_corresponding":false,"raw_author_name":"Tudor Ciuleanu","raw_affiliation_strings":["Institute of Oncology Ion Chiricuta, Cluj-Napoca, Cluj"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Oncology Ion Chiricuta, Cluj-Napoca, Cluj","institution_ids":["https://openalex.org/I4210100616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090671983","display_name":"Giuseppe Aprile","orcid":"https://orcid.org/0000-0003-2007-4077","observed_orcids":["https://orcid.org/0000-0003-2007-4077"]},"institutions":[{"id":"https://openalex.org/I129043915","display_name":"University of Udine","ror":"https://ror.org/05ht0mh31","country_code":"IT","type":"education","lineage":["https://openalex.org/I129043915"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giuseppe Aprile","raw_affiliation_strings":["University Hospital of Udine, Udine, UD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital of Udine, Udine, UD","institution_ids":["https://openalex.org/I129043915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003643368","display_name":"Malcolm J. Moore","orcid":"https://orcid.org/0009-0007-7493-3558","observed_orcids":["https://orcid.org/0009-0007-7493-3558"]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Malcolm Moore","raw_affiliation_strings":["Princess Margaret Hospital, Toronto, ON"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Princess Margaret Hospital, Toronto, ON","institution_ids":["https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032050013","display_name":"Irena Federowicz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Irena Federowicz","raw_affiliation_strings":["NZOZ Magodent, Warsaw, Masovia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NZOZ Magodent, Warsaw, Masovia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023909576","display_name":"Jean\u2010Luc Van Laethem","orcid":"https://orcid.org/0000-0002-0785-0580","observed_orcids":["https://orcid.org/0000-0002-0785-0580"]},"institutions":[{"id":"https://openalex.org/I2802054198","display_name":"Erasmus Hospital","ror":"https://ror.org/05j1gs298","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2802054198"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Jean Luc Van Laethem","raw_affiliation_strings":["Erasme University Hospital, ULB Brussels, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Erasme University Hospital, ULB Brussels, Brussels, Belgium","institution_ids":["https://openalex.org/I2802054198"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074026718","display_name":"Chiun Hsu","orcid":"https://orcid.org/0000-0002-1122-0055","observed_orcids":["https://orcid.org/0000-0002-1122-0055"]},"institutions":[{"id":"https://openalex.org/I4210131804","display_name":"National Taiwan University Hospital","ror":"https://ror.org/03nteze27","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I4210131804"]}],"countries":["TW"],"is_corresponding":false,"raw_author_name":"Chiun Hsu","raw_affiliation_strings":["National Taiwan University Hospital, Taipei,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Taiwan University Hospital, Taipei,","institution_ids":["https://openalex.org/I4210131804"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101854397","display_name":"Sajid Ali","orcid":"https://orcid.org/0000-0003-3033-280X","observed_orcids":["https://orcid.org/0000-0003-3033-280X","https://orcid.org/0000-0002-1477-6876"]},"institutions":[{"id":"https://openalex.org/I4210113058","display_name":"Roche (United Kingdom)","ror":"https://ror.org/024tgbv41","country_code":"GB","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210113058"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sajid Ali","raw_affiliation_strings":["Roche Products Ltd., Welwyn Garden City, Hertfordshire"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Products Ltd., Welwyn Garden City, Hertfordshire","institution_ids":["https://openalex.org/I4210113058"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067529518","display_name":"Zsuzsanna Csutor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Zsuzsanna Csutor","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd, Basal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd, Basal","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046813938","display_name":"Xianhua Meng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210119458","display_name":"Roche (China)","ror":"https://ror.org/02hv5e369","country_code":"CN","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210119458"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xianhua Meng","raw_affiliation_strings":["Roche Product Development in Asia Pacific, Shanghai, Pudong"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Product Development in Asia Pacific, Shanghai, Pudong","institution_ids":["https://openalex.org/I4210119458"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042673919","display_name":"Chung\u2010Pin Li","orcid":"https://orcid.org/0000-0003-2123-8264","observed_orcids":["https://orcid.org/0000-0003-2123-8264"]},"institutions":[{"id":"https://openalex.org/I2803004286","display_name":"Taipei Veterans General Hospital","ror":"https://ror.org/03ymy8z76","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I2803004286"]},{"id":"https://openalex.org/I4210087978","display_name":"Centre Hospitalier Universitaire de Besan\u00e7on","ror":"https://ror.org/0084te143","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210087978"]},{"id":"https://openalex.org/I4387156312","display_name":"National Yang Ming University","ror":"https://ror.org/009h5ks85","country_code":"TW","type":"education","lineage":["https://openalex.org/I148366613","https://openalex.org/I4387156312"]}],"countries":["FR","TW"],"is_corresponding":false,"raw_author_name":"Chung-Pin Li","raw_affiliation_strings":["CHU Jean Minjoz , Besancon ,","Taipei Veterans General Hospital and National Yang-Ming University, Taipei"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CHU Jean Minjoz , Besancon ,","institution_ids":["https://openalex.org/I4210087978"]},{"raw_affiliation_string":"Taipei Veterans General Hospital and National Yang-Ming University, Taipei","institution_ids":["https://openalex.org/I2803004286","https://openalex.org/I4387156312"]}]}],"institutions":[],"countries_distinct_count":9,"institutions_distinct_count":12,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5080,"currency":"USD","value_usd":5080},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"23","issue":null,"first_page":"iv6","last_page":"iv7"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/erlotinib","display_name":"erlotinib","score":0.9559999704360962},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.9879999756813049},{"id":"https://openalex.org/keywords/metastatic-pancreatic-cancer","display_name":"metastatic pancreatic cancer","score":0.9309999942779541},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.8109999895095825},{"id":"https://openalex.org/keywords/skin-rash","display_name":"rash","score":0.8149999976158142},{"id":"https://openalex.org/keywords/egfr-inhibitors","display_name":"EGFR inhibitors","score":0.7730000019073486},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7279999852180481},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9259999990463257},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.46700000762939453},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.6389999985694885},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.41200000047683716},{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.6150000095367432},{"id":"https://openalex.org/keywords/response-rate","display_name":"response rate","score":0.33000001311302185}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9494779706001282},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.9304713010787964},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.8889639377593994},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.8212647438049316},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.5554603934288025},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5526448488235474},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5133129954338074},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4581663906574249},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4338036775588989},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.26300448179244995},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.10722813010215759}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s0923-7534(19)66471-9","doi":"https://doi.org/10.1016/s0923-7534(19)66471-9","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s0923-7534(19)66471-9","pdf_url":"https://doi.org/10.1016/s0923-7534(19)66471-9","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/s0923-7534(19)66471-9","doi":"https://doi.org/10.1016/s0923-7534(19)66471-9","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s0923-7534(19)66471-9","pdf_url":"https://doi.org/10.1016/s0923-7534(19)66471-9","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3000707262.pdf","grobid_xml":"https://content.openalex.org/works/W3000707262.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1972415660","https://openalex.org/W2247844991","https://openalex.org/W2590986852","https://openalex.org/W3005572112","https://openalex.org/W2595507622","https://openalex.org/W562529261","https://openalex.org/W2884162467","https://openalex.org/W2034504987","https://openalex.org/W1831167137","https://openalex.org/W2591058986"],"abstract_inverted_index":null,"counts_by_year":[{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2020-01-23T00:00:00"}